- £1.25bn
- £1.11bn
- £218.23m
- 92
- 35
- 63
- 72
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 105 | 127 | 146 | 164 | 218 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 67.5 | 77.5 | 90 | 105 | 132 |
Operating Profit | 37.4 | 49.2 | 55.9 | 59 | 86.2 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 37.7 | 48.5 | 55.1 | 58.4 | 87.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 30.4 | 38.8 | 43.8 | 46.7 | 68.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 30.4 | 38.8 | 43.8 | 46.7 | 68.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 30.4 | 38.8 | 43.8 | 46.7 | 68.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.077 | 0.095 | 0.107 | 0.114 | 0.165 |
Dividends per Share | |||||
Special Dividends per Share |